Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Sales (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Return on Sales for 15 consecutive years, with 1.19% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 119.0% year-over-year to 1.19%, compared with a TTM value of 0.37% through Sep 2025, down 30.0%, and an annual FY2024 reading of 0.11%, down 5.0% over the prior year.
  • Return on Sales was 1.19% for Q3 2025 at Sanara MedTech, down from 0.07% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.08% in Q2 2022 and bottomed at 1.19% in Q3 2025.
  • Average Return on Sales over 5 years is 0.21%, with a median of 0.14% recorded in 2025.
  • The sharpest move saw Return on Sales increased 28bps in 2023, then tumbled -119bps in 2025.
  • Year by year, Return on Sales stood at 0.49% in 2021, then skyrocketed by 43bps to 0.27% in 2022, then surged by 95bps to 0.01% in 2023, then tumbled by -326bps to 0.06% in 2024, then tumbled by -1778bps to 1.19% in 2025.
  • Business Quant data shows Return on Sales for SMTI at 1.19% in Q3 2025, 0.07% in Q2 2025, and 0.14% in Q1 2025.